Inactive Instrument
Tricida, Inc. Share Price
Stocks
TCDA
US89610F1012
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -99.90% |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Alpern
BRD | Director/Board Member | 75 | 01/10/2013 |
| Director/Board Member | - | 09/01/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/11/22 | Sell | Director | 1,31,879 | 0.2369% | ||
| 22/11/22 | OrbiMed Advisors Private Equity
| Sell | Company | 1,02,80,947 | 18.4680% | |
| 22/11/22 | OrbiMed Advisors Private Equity
| Sell | Company | 1,02,80,947 | 18.4680% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -99.90% | -99.92% | - | - | 580 | |
| +0.34% | +1.12% | +34.75% | +61.06% | 6.44TCr | |
| -0.27% | +2.56% | +14.21% | +83.40% | 5.62TCr | |
| +0.67% | +2.01% | +13.30% | +103.69% | 5.42TCr | |
| -1.43% | -1.17% | +26.27% | +52.86% | 4.53TCr | |
| -0.48% | -2.80% | +18.01% | +117.99% | 4.22TCr | |
| +0.82% | +1.37% | +227.94% | +922.41% | 4.08TCr | |
| +0.20% | +42.73% | +103.77% | +88.74% | 3.38TCr | |
| -0.26% | -2.57% | +12.55% | +45.18% | 3.22TCr | |
| -1.60% | -3.23% | +21.16% | -12.24% | 2.36TCr | |
| Average | -10.20% | +4.50% | +52.44% | +162.57% | 4.36TCr | |
| Weighted average by Cap. | -0.12% | +3.60% | +49.44% | +161.45% |
Employees
57
